Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.340
-0.220 (-6.18%)
May 2, 2025, 4:00 PM EDT - Market closed

Lipocine Revenue

In the year 2024, Lipocine had annual revenue of $11.20M, down -492.80%. Lipocine had revenue of $3.49M in the quarter ending December 31, 2024, with 1,514.99% growth.

Revenue (ttm)
$11.20M
Revenue Growth
-492.80%
P/S Ratio
1.59
Revenue / Employee
$699,884
Employees
16
Market Cap
17.87M

Revenue Chart

Created with Highcharts 11.4.8Lipocine Revenue - Annual16.14M16.14M500.00K500.00K-2.85M-2.85M11.20M11.20M20202021202220232024-5M10M15M

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.20M14.05M-492.80%
Dec 31, 2023-2.85M-3.35M-670.16%
Dec 31, 2022500.00K-15.64M-96.90%
Dec 31, 202116.14M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.